Browse Related Topics For:

Hatch-Waxman

178
Pharmaceutical Industry
175
Patents
171
Generic Drugs
159
Pharmaceutical Patents
148
Patent Infringement
133
Patent Litigation
117
ANDA
110
Prescription Drugs
92
FDA
45
Patent-in-Suit
37
SCOTUS
33
FTC
33
Reverse Payment Settlement Agreements
32
FTC v Actavis
21
Mylan Pharmaceuticals
19
Pay-For-Delay
19
Teva Pharmaceuticals
18
Personal Jurisdiction
16
Actavis Inc.
16
BPCIA
16
Popular
15
Antitrust Litigation
15
Inter Partes Review (IPR) Proceeding
14
Biosimilars
14
Watson Pharmaceuticals
13
Appeals
13
Sandoz
12
Intellectual Property Protection
12
Patent Trial and Appeal Board
11
AstraZeneca
10
Anti-Competitive
10
Settlement
9
America Invents Act
9
Apotex
9
Safe Harbors
8
Claim Construction
8
Merck
8
Patent Applications
8
Prior Art
8
Rule-of-Reason Analysis
8
Sherman Act
7
Biologics
7
Cephalon
7
DaimlerChrysler v Bauman
7
Eli Lilly
7
Endo Pharmaceuticals
7
Obviousness
7
Otsuka Pharmaceutical
7
Sandoz v Amgen
7
USPTO
6
Amgen
6
Bayer
6
Corporate Counsel
6
Declaratory Judgments
6
FDCA
6
GlaxoSmithKline
6
Hospira
6
Motion to Dismiss
6
Novartis
6
Orange Book
6
Preliminary Injunctions
6
Summary Judgment
6
Warner Chilcott
5
Antitrust Violations
5
Class Action
5
Classen Immunotherapies
5
Commercial Marketing
5
FDA Approval
5
Induced Infringement
5
Infringement
5
No-AG Agreement
5
Patent Invalidity
5
Patent Reform
5
Patent-Eligible Subject Matter
5
Preemption
5
Teva v Sandoz
4
Allergan Inc
4
Elan Pharmaceuticals
4
Federal Rule 12(b)(6)
4
Jurisdiction
4
Labeling
4
Minimum Contacts
4
Patent Dance
4
Pleading Standards
4
Product Hopping
4
Roxane Laboratories
4
Specific Jurisdiction
4
Standard of Review
4
Takeda Pharmaceuticals
3
Allergan v Sandoz
3
Antitrust Provisions
3
Biologics Price Competition and Innovation Act of 2009
3
Biotechnology
3
De Novo Standard of Review
3
Discovery
3
Disgorgement
3
Dismissals
3
Exclusivity
3
Failure To Warn
3
Healthcare
3
Hedge Funds
3
Innovation Act
3
Manufacturers
3
Noninfringement
3
Notice Requirements
3
Patent Trolls
3
Product Exclusivity
3
Putative Class Actions
3
Reverse Payments
3
Shire Development v Watson
3
Spectrum
3
Standing
3
Subject Matter Jurisdiction
3
Unfair Competition
2
aBLA
2
Amarin
2
Article III
2
Brand
2
Burden of Proof
2
CA Supreme Court
2
Cartwright Act
2
Certiorari
2
Competition
2
DaimlerAG
2
Damages
2
Disclosure Requirements
2
Doctrine of Equivalents
2
Forum Shopping
2
Fresenius
2
Generic
2
Genzyme
2
Injunctions
2
Innovation
2
Intellectual Property Litigation
2
Licensing Rules
2
Life Sciences
2
Mayo v. Prometheus
2
Medicare Modernization Act
2
Method Claims
2
Monopolization
2
Motion To Stay
2
Mutual Pharmaceuticals v Bartlett
2
Nexium
2
Non-Practicing Entities
2
On-Sale Bar
2
Orphan Drugs
2
Pfizer
2
PLIVA v Mensing
2
Presumption of Validity
2
Proposed Regulation
2
SmithKline Beecham
2
SNDAs
2
Validity
2
Written Descriptions
1
Abbott Laboratories
1
AbbVie
1
Abuse of Process
1
Affordable Care Act
1
Amicus Briefs
1
AMP v Myriad
1
Annual Reports
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Injuries
1
Antitrust Standing
1
Attorney Disbarrment
1
Attorney-Client Privilege
1
Australia
1
Automatic Stay
1
Balancing Test
1
Bifurcation
1
Biofuel
1
Biogen Idec
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Bowman v Monsanto
1
Broadest Reasonable Interpretation Standard
1
Burden-Shifting
1
But For Causation
1
CAFA
1
Cancer
1
Causation
1
Chevron Deference
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
CLS Bank v Alice Corp
1
Coca Cola
1
Collateralized Debt Obligations
1
Combination Products
1
Comment Period
1
Compliance
1
Congressional Committees
1
Consent Order
1
Consideration
1
Contraceptives
1
Controlled Substances Act
1
Counterclaims
1
Covered Business Method Patents
1
Covered Business Method Proceedings
1
Cuozzo Speed Technologies
1
Dart Cherokee Basin Operating Co. v. Owens
1
Data Protection
1
DEA
1
Death Penalty
1
Dell
1
Denial of Certiorari
1
Design Defects
1
Design Patent
1
Direct Purchasers
1
Dirks v SEC
1
Discovery Schedule
1
DNA
1
Drug Approvals
1
Drug Compounding
1
Drug Safety
1
Duty to Deal
1
Duty to Update
1
eBay
1
Emerging Markets
1
Employer Mandates
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
EPA
1
Estoppel
1
European Patent Office
1
Exemptions
1
Expert Testimony
1
Exports
1
Extrinsic Evidence
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Financial Crisis
1
Foreign Corporations
1
Foreign Defendants
1
Forest Laboratories
1
Forum
1
Forum Non Conveniens
1
Forum Selection
1
Fraud
1
General Jurisdiction
1
Goodyear
1
Hague Convention
1
Healthcare Costs
1
Hindsight Reconstruction
1
Human Genes
1
India
1
Injury-in-Fact
1
Innovator Liability
1
Insider Trading
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Internal Investigations
1
Inventions
1
ITC
1
Jazz Pharmaceuticals
1
Joinder
1
Jury Verdicts
1
Justiciable Controversy
1
KBR (formerly Kellogg Brown & Root)
1
Laches
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Loss Causation
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Markman Hearing
1
Material Misrepresentation
1
Medical Devices
1
Medical Research
1
Misrepresentation
1
Monsanto
1
Morgan Stanley
1
Motion for Reconsideration
1
Motion to Amend
1
Myriad
1
New Trial
1
Nintendo
1
Non-Appealable Decisions
1
Off-Label Use
1
Omissions
1
Omnicare v Laborers District Council
1
Opioid
1
Oral Argument
1
Out-of-State Companies
1
OxyContin
1
Par Pharmaceutical
1
Patent Agent Privilege
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent-Misuse
1
Patentability Search
1
Pending Legislation
1
Permanent Injunctions
1
Personal Benefit
1
Petition For Rehearing
1
PHRMA
1
Pleadings
1
POM Wonderful
1
Post-Grant Review
1
Presidential Elections
1
Price Manipulation
1
Prilosec
1
Prioritized Examination
1
Privilege Waivers
1
Proctor & Gamble
1
Product Defects
1
Product Labels
1
Product of Nature Doctrine
1
Professional Conferences
1
Prometheus
1
Proposed Amendments
1
Quality Control Plan
1
RanBaxy
1
Registration Requirement
1
Regulatory Agenda
1
Reissue Patents
1
Removal
1
Research and Development
1
Restraining Orders
1
Reversal
1
RICO
1
Ripeness
1
ROI
1
Royalties
1
Rule 26
1
Rulemaking Process
1
Sales Contracts
1
Sanofi
1
Scienter
1
Scope of Discovery Requests
1
Section 337
1
Sham Litigation Exception
1
Single Occurrence
1
Standard of Proof
1
State Law Tort Claims
1
STRONG Patents Act
1
Supplemental Examination
1
Supply Chain
1
Tolling
1
Trademark Infringement
1
TRIPS Agreement
1
TRO
1
Tyco
1
Uniform Commercial Code (UCC)
1
USDA
1
Vacated
1
Vaccinations
1
Valuation
1
Veterinarians
1
Veterinary Products
1
Warning Labels
1
White Collar Crimes
1
WIPO
1
Work Product Privilege
1
World Intellectual Property Organisation
Feedback? Tell us what you think of the new jdsupra.com!